Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	adenylate cyclase activity	NPR1 NPR2 ADCY5 ADCY6	1.66e-05	18	177	4	GO:0004016
GeneOntologyMolecularFunction	cyclase activity	NPR1 NPR2 ADCY5 ADCY6	5.52e-05	24	177	4	GO:0009975
GeneOntologyMolecularFunction	phosphorus-oxygen lyase activity	NPR1 NPR2 ADCY5 ADCY6	6.53e-05	25	177	4	GO:0016849
GeneOntologyMolecularFunction	arylamine N-acetyltransferase activity	NAT1 NAT2	2.33e-04	3	177	2	GO:0004060
GeneOntologyMolecularFunction	natriuretic peptide receptor activity	NPR1 NPR2	2.33e-04	3	177	2	GO:0016941
GeneOntologyMolecularFunction	transcription regulator inhibitor activity	ID1 ID2 ID4 PKD1	2.82e-04	36	177	4	GO:0140416
GeneOntologyBiologicalProcess	negative regulation of neuron differentiation	ID2 ID4 MED1 TTC3 CIT NR2E1 TP73	1.54e-05	94	175	7	GO:0045665
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	SLC25A46 TNIK DDR1 NPR2 MYO9B SYNE1 ID1 TTC3 CIT SEMA4G AMIGO1 IQGAP1 SPG21 SS18L1 NR2E1 VPS13A DNM3 SLC9A6 TBCE DNM2	2.20e-05	819	175	20	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	SLC25A46 TNIK DDR1 NPR2 MYO9B SYNE1 ID1 TTC3 CIT SEMA4G AMIGO1 IQGAP1 SPG21 SS18L1 NR2E1 VPS13A DNM3 SLC9A6 TBCE DNM2	2.49e-05	826	175	20	GO:0048858
GeneOntologyBiologicalProcess	cyclic purine nucleotide metabolic process	NPR1 NPR2 ADCY5 ADCY6 PDE5A	3.45e-05	44	175	5	GO:0052652
GeneOntologyBiologicalProcess	cyclic nucleotide metabolic process	NPR1 NPR2 ADCY5 ADCY6 PDE5A	3.85e-05	45	175	5	GO:0009187
GeneOntologyBiologicalProcess	cyclic nucleotide biosynthetic process	NPR1 NPR2 ADCY5 ADCY6	3.91e-05	23	175	4	GO:0009190
GeneOntologyBiologicalProcess	neuron development	SLC25A46 TNIK DDR1 NPR2 SYNE1 INPPL1 CEP290 ID1 ID2 BRINP1 TTC3 CIT ADCY6 SEMA4G AMIGO1 IQGAP1 SPG21 MAGI2 SS18L1 NR2E1 VPS13A DNM3 HERC1 SLC9A6 ACAP3 TP73 TBCE DNM2	4.21e-05	1463	175	28	GO:0048666
GeneOntologyBiologicalProcess	neuron projection morphogenesis	SLC25A46 TNIK DDR1 NPR2 SYNE1 ID1 TTC3 CIT SEMA4G AMIGO1 IQGAP1 SPG21 SS18L1 NR2E1 VPS13A DNM3 SLC9A6 TBCE DNM2	5.38e-05	802	175	19	GO:0048812
GeneOntologyBiologicalProcess	endomembrane system organization	SH3TC2 VPS18 XKR9 GPER1 SYNE1 SPTB HUWE1 ALS2CL CIT LYST SPTBN5 CATSPER1 COG6 SMPD1 PLEC ARMH3 DNM2	6.12e-05	672	175	17	GO:0010256
GeneOntologyBiologicalProcess	cell morphogenesis	SLC25A46 TNIK DDR1 NPR2 MYO9B SYNE1 ID1 ID2 MED1 TTC3 CIT SEMA4G AMIGO1 IQGAP1 SPG21 SS18L1 NR2E1 VPS13A DNM3 PLEC CDH8 SLC9A6 TBCE DNM2	7.46e-05	1194	175	24	GO:0000902
GeneOntologyBiologicalProcess	heart development	AKAP6 GPER1 SYNE1 CEP290 ID1 ID2 FHOD3 RB1CC1 MED1 RYR2 TBC1D32 ADRA1A PKD1 ATM PLEC MAPK11 TP73 DNM2	8.15e-05	757	175	18	GO:0007507
GeneOntologyBiologicalProcess	microtubule-based process	HAUS7 DNAH10 CEP290 DNAH2 TOGARAM1 APOB RSPH6A LYST TBC1D32 RASGRP1 SLC9C1 CATSPER1 PKD1 VPS13A TTC21B WRAP73 NINL ANKFN1 WDR62 DEUP1 TBCE DNM2	9.38e-05	1058	175	22	GO:0007017
GeneOntologyBiologicalProcess	glial cell differentiation	SLC25A46 SH3TC2 TRPC4 ID2 ID4 ADAM22 NR2E1 VPS13A TTC21B PLEC TP73	9.74e-05	321	175	11	GO:0010001
GeneOntologyBiologicalProcess	protein-containing complex localization	AKAP6 TNIK SYNE1 USP46 ADAM22 MAGI2 MDN1 TTC21B DNM3 ATM	1.37e-04	278	175	10	GO:0031503
GeneOntologyBiologicalProcess	peripheral nervous system axon ensheathment	SLC25A46 SH3TC2 ADAM22 PLEC	1.69e-04	33	175	4	GO:0032292
GeneOntologyBiologicalProcess	myelination in peripheral nervous system	SLC25A46 SH3TC2 ADAM22 PLEC	1.69e-04	33	175	4	GO:0022011
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection assembly	TNIK SYNE1 INPPL1 CEP290 DNAH2 TOGARAM1 RSPH6A NUDCD3 RFX4 TBC1D32 TTC21B WRAP73 DNM3 PLD1 MACIR DNM2	1.96e-04	670	175	16	GO:0120031
GeneOntologyBiologicalProcess	vacuolar transport	VPS18 ZFYVE16 VPS39 LYST SPTBN5 VIPAS39 TGFBRAP1 VPS13A	2.01e-04	187	175	8	GO:0007034
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	SLC25A46 TNIK NPR2 SYNE1 ID1 ID2 TTC3 CIT SEMA4G AMIGO1 SPG21 SS18L1 NR2E1 DNM3 SLC9A6 TBCE DNM2	2.21e-04	748	175	17	GO:0048667
GeneOntologyBiologicalProcess	neuron projection development	SLC25A46 TNIK DDR1 NPR2 SYNE1 INPPL1 ID1 TTC3 CIT ADCY6 SEMA4G AMIGO1 IQGAP1 SPG21 MAGI2 SS18L1 NR2E1 VPS13A DNM3 HERC1 SLC9A6 ACAP3 TBCE DNM2	2.27e-04	1285	175	24	GO:0031175
GeneOntologyBiologicalProcess	regulation of neuron projection development	TNIK DDR1 SYNE1 INPPL1 ID1 TTC3 CIT ADCY6 AMIGO1 IQGAP1 MAGI2 SS18L1 NR2E1 DNM3 ACAP3	2.36e-04	612	175	15	GO:0010975
GeneOntologyBiologicalProcess	regulation of dendrite morphogenesis	TNIK SYNE1 ID1 CIT SS18L1 NR2E1	2.48e-04	103	175	6	GO:0048814
GeneOntologyBiologicalProcess	cell projection assembly	TNIK SYNE1 INPPL1 CEP290 DNAH2 TOGARAM1 RSPH6A NUDCD3 RFX4 TBC1D32 TTC21B WRAP73 DNM3 PLD1 MACIR DNM2	2.51e-04	685	175	16	GO:0030031
GeneOntologyBiologicalProcess	regulation of SNARE complex assembly	VPS18 VPS39 TGFBRAP1	2.53e-04	15	175	3	GO:0035542
GeneOntologyBiologicalProcess	organelle assembly	HAUS7 WIPI1 SYNE1 CEP290 DNAH2 TOGARAM1 FHOD3 RSPH6A NUDCD3 RB1CC1 RFX4 TBC1D32 VIPAS39 MDN1 TTC21B WRAP73 ATM PLEC MACIR WDR62 DEUP1 DNM2	2.63e-04	1138	175	22	GO:0070925
GeneOntologyBiologicalProcess	regulation of dendrite development	TNIK SYNE1 ID1 CIT IQGAP1 SS18L1 NR2E1	2.98e-04	150	175	7	GO:0050773
GeneOntologyBiologicalProcess	autophagy of peroxisome	WIPI1 RB1CC1 ATM	3.10e-04	16	175	3	GO:0030242
GeneOntologyBiologicalProcess	endosomal vesicle fusion	VPS18 VPS39 TGFBRAP1	3.10e-04	16	175	3	GO:0034058
GeneOntologyBiologicalProcess	lysosomal transport	VPS18 ZFYVE16 VPS39 LYST SPTBN5 VIPAS39 TGFBRAP1	3.11e-04	151	175	7	GO:0007041
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	TNIK DDR1 SYNE1 INPPL1 ID1 TTC3 CIT ADCY6 AMIGO1 IQGAP1 MAGI2 SS18L1 NR2E1 WRAP73 DNM3 PLD1 ACAP3 DNM2	3.20e-04	846	175	18	GO:0120035
GeneOntologyBiologicalProcess	growth	AKAP6 DDR1 NPR1 NPR2 FLT4 POT1 MED1 ST7L TTC3 IQGAP1 SPG21 MAGI2 ADRA1A BNIPL VPS13A ATM DMBT1 PLEC MAPK11 SLC9A6 TP73 TBCE DNM2	3.23e-04	1235	175	23	GO:0040007
GeneOntologyBiologicalProcess	regulation of neuron differentiation	ID2 ID4 BRINP1 MED1 TTC3 CIT NR2E1 WDR62 TP73	3.40e-04	255	175	9	GO:0045664
GeneOntologyBiologicalProcess	mitotic cell cycle	TTC28 DBF4B ID2 ID4 BRINP1 CIT NEK9 IQGAP1 CCNH ANAPC1 PKD1 WRAP73 ATM DNA2 ANKFN1 ANAPC5 WDR62 TP73 TBCE DNM2	3.95e-04	1014	175	20	GO:0000278
GeneOntologyBiologicalProcess	regulation of cell projection organization	TNIK DDR1 SYNE1 INPPL1 ID1 TTC3 CIT ADCY6 AMIGO1 IQGAP1 MAGI2 SS18L1 NR2E1 WRAP73 DNM3 PLD1 ACAP3 DNM2	4.06e-04	863	175	18	GO:0031344
GeneOntologyBiologicalProcess	cilium assembly	SYNE1 CEP290 DNAH2 TOGARAM1 RSPH6A NUDCD3 RFX4 TBC1D32 TTC21B WRAP73 MACIR DNM2	4.25e-04	444	175	12	GO:0060271
GeneOntologyBiologicalProcess	actomyosin contractile ring assembly actin filament organization	IQGAP1 PLEC	4.25e-04	4	175	2	GO:2000689
GeneOntologyBiologicalProcess	circadian regulation of gene expression	ID1 ID2 ID4 HUWE1 RORC	4.44e-04	75	175	5	GO:0032922
GeneOntologyBiologicalProcess	cerebellar Purkinje cell differentiation	SLC25A46 TTC21B HERC1	4.46e-04	18	175	3	GO:0021702
GeneOntologyBiologicalProcess	regulation of neurogenesis	TNIK GPER1 ID1 ID2 ID4 BRINP1 TTC3 CIT AMIGO1 SS18L1 NR2E1 WDR62 TP73	4.69e-04	515	175	13	GO:0050767
GeneOntologyBiologicalProcess	cardiac muscle tissue development	AKAP6 SYNE1 ID2 FHOD3 MED1 RYR2 ADRA1A PLEC MAPK11 TP73	4.98e-04	327	175	10	GO:0048738
GeneOntologyBiologicalProcess	circulatory system development	AKAP6 NPR1 NPR2 FLT4 GPER1 SYNE1 CEP290 ID1 ID2 FHOD3 APOB RB1CC1 MED1 RYR2 TBC1D32 JUP ADRA1A PXDN NR2E1 PKD1 ATM PLEC MAPK11 TP73 DNM2	5.09e-04	1442	175	25	GO:0072359
GeneOntologyBiologicalProcess	regulation of postsynaptic membrane neurotransmitter receptor levels	TNIK SYNE1 USP46 ADAM22 MAGI2 DNM3 SLC9A6	5.11e-04	164	175	7	GO:0099072
GeneOntologyBiologicalProcess	cGMP metabolic process	NPR1 NPR2 PDE5A	5.26e-04	19	175	3	GO:0046068
GeneOntologyBiologicalProcess	non-motile cilium assembly	CEP290 TOGARAM1 TBC1D32 WRAP73 DNM2	5.32e-04	78	175	5	GO:1905515
GeneOntologyBiologicalProcess	Golgi organization	SYNE1 HUWE1 CIT SPTBN5 COG6 ARMH3 DNM2	5.90e-04	168	175	7	GO:0007030
GeneOntologyBiologicalProcess	dendrite development	SLC25A46 TNIK SYNE1 ID1 CIT IQGAP1 SS18L1 NR2E1 DNM3 SLC9A6	6.01e-04	335	175	10	GO:0016358
GeneOntologyBiologicalProcess	cerebellar Purkinje cell layer formation	SLC25A46 TTC21B HERC1	6.15e-04	20	175	3	GO:0021694
GeneOntologyBiologicalProcess	base-excision repair	PARG HUWE1 POLQ DNA2	6.19e-04	46	175	4	GO:0006284
GeneOntologyBiologicalProcess	Schwann cell development	SLC25A46 SH3TC2 ADAM22 PLEC	6.72e-04	47	175	4	GO:0014044
GeneOntologyBiologicalProcess	negative regulation of neurogenesis	ID1 ID2 ID4 BRINP1 TTC3 CIT NR2E1	7.02e-04	173	175	7	GO:0050768
GeneOntologyBiologicalProcess	peripheral nervous system neuron axonogenesis	SLC25A46 TBCE	7.04e-04	5	175	2	GO:0048936
GeneOntologyBiologicalProcess	endosome to lysosome transport	VPS18 VPS39 LYST VIPAS39 TGFBRAP1	7.46e-04	84	175	5	GO:0008333
GeneOntologyBiologicalProcess	developmental growth	AKAP6 DDR1 NPR2 MED1 TTC3 IQGAP1 SPG21 MAGI2 ADRA1A VPS13A ATM DMBT1 PLEC MAPK11 SLC9A6 TP73 TBCE DNM2	7.63e-04	911	175	18	GO:0048589
GeneOntologyBiologicalProcess	cilium organization	SYNE1 CEP290 DNAH2 TOGARAM1 RSPH6A NUDCD3 RFX4 TBC1D32 TTC21B WRAP73 MACIR DNM2	7.83e-04	476	175	12	GO:0044782
GeneOntologyBiologicalProcess	membrane organization	SLC25A46 SH3TC2 VPS18 XKR9 GPER1 VPS39 SPTB HUWE1 ELMO1 MAGI2 VIPAS39 CATSPER1 TGFBRAP1 DNAJC11 DNM3 SMPD1 PLEC DNM2	7.92e-04	914	175	18	GO:0061024
GeneOntologyBiologicalProcess	striated muscle tissue development	AKAP6 SYNE1 ID2 FHOD3 MED1 RYR2 ADRA1A PLEC MAPK11 TP73	8.22e-04	349	175	10	GO:0014706
GeneOntologyCellularComponent	cilium	NPR2 IMPG1 DNAH10 CEP290 DNAH2 AKAP3 TOGARAM1 RSPH6A ADCY5 ADCY6 SPTBN5 MAGI2 TBC1D32 SLC9C1 CATSPER1 MROH2B PKD1 VPS13A TTC21B PRKACG WRAP73 MACIR	8.44e-06	898	178	22	GO:0005929
GeneOntologyCellularComponent	HOPS complex	VPS18 VPS39 VIPAS39	2.06e-04	14	178	3	GO:0030897
GeneOntologyCellularComponent	dendritic spine head	GPER1 SYNE1 DNM3	3.13e-04	16	178	3	GO:0044327
GeneOntologyCellularComponent	vesicle tethering complex	VPS18 VPS39 VIPAS39 COG6 TGFBRAP1	3.73e-04	72	178	5	GO:0099023
GeneOntologyCellularComponent	calcium channel complex	AKAP6 TRPC4 RYR2 CATSPER1 PKD1	3.98e-04	73	178	5	GO:0034704
GeneOntologyCellularComponent	photoreceptor inner segment	USP45 IMPG1 MAGI2 DNM3 DNM2	5.41e-04	78	178	5	GO:0001917
Domain	ARM-type_fold	PDS5B NBEAL1 TOGARAM1 FHOD3 APOB HUWE1 LYST ELMO1 ARFGEF3 RANBP17 JUP HEATR6 MROH2B CTNNBL1 ATM ARMH3	1.42e-07	339	176	16	IPR016024
Domain	ACTININ_2	SYNE1 SPTB SPTBN5 PLEC PLS3	2.06e-06	23	176	5	PS00020
Domain	ACTININ_1	SYNE1 SPTB SPTBN5 PLEC PLS3	2.06e-06	23	176	5	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 SPTB SPTBN5 PLEC PLS3	2.06e-06	23	176	5	IPR001589
Domain	CH	SYNE1 SPTB LRCH1 IQGAP1 SPTBN5 PLEC PLS3	2.57e-06	65	176	7	SM00033
Domain	DNA-bd_prot-inh	ID1 ID2 ID4	3.27e-06	4	176	3	IPR026052
Domain	CH	SYNE1 SPTB LRCH1 IQGAP1 SPTBN5 PLEC PLS3	4.26e-06	70	176	7	PF00307
Domain	-	SYNE1 SPTB LRCH1 IQGAP1 SPTBN5 PLEC PLS3	4.69e-06	71	176	7	1.10.418.10
Domain	CH	SYNE1 SPTB LRCH1 IQGAP1 SPTBN5 PLEC PLS3	5.65e-06	73	176	7	PS50021
Domain	CH-domain	SYNE1 SPTB LRCH1 IQGAP1 SPTBN5 PLEC PLS3	6.78e-06	75	176	7	IPR001715
Domain	CNH	TNIK VPS39 CIT TGFBRAP1	9.59e-06	15	176	4	PF00780
Domain	CNH	TNIK VPS39 CIT TGFBRAP1	9.59e-06	15	176	4	PS50219
Domain	CNH_dom	TNIK VPS39 CIT TGFBRAP1	9.59e-06	15	176	4	IPR001180
Domain	SPEC	AKAP6 SYNE1 SPTB SPTBN5 PLEC	1.15e-05	32	176	5	SM00150
Domain	Spectrin/alpha-actinin	AKAP6 SYNE1 SPTB SPTBN5 PLEC	1.15e-05	32	176	5	IPR018159
Domain	A/G_cyclase_CS	NPR1 NPR2 ADCY5 ADCY6	1.65e-05	17	176	4	IPR018297
Domain	-	NPR1 NPR2 ADCY5 ADCY6	2.10e-05	18	176	4	3.30.70.1230
Domain	Nucleotide_cyclase	NPR1 NPR2 ADCY5 ADCY6	2.10e-05	18	176	4	IPR029787
Domain	Guanylate_cyc	NPR1 NPR2 ADCY5 ADCY6	2.64e-05	19	176	4	PF00211
Domain	GUANYLATE_CYCLASE_2	NPR1 NPR2 ADCY5 ADCY6	2.64e-05	19	176	4	PS50125
Domain	A/G_cyclase	NPR1 NPR2 ADCY5 ADCY6	2.64e-05	19	176	4	IPR001054
Domain	GUANYLATE_CYCLASE_1	NPR1 NPR2 ADCY5 ADCY6	2.64e-05	19	176	4	PS00452
Domain	CYCc	NPR1 NPR2 ADCY5 ADCY6	2.64e-05	19	176	4	SM00044
Domain	TPR_REGION	SH3TC2 TTC28 DNAH10 DNAH2 TTC3 VPS13A TTC21B PRMT9 ANAPC5	2.71e-05	165	176	9	PS50293
Domain	TPR	SH3TC2 TTC28 DNAH10 DNAH2 TTC3 VPS13A TTC21B PRMT9 ANAPC5	2.71e-05	165	176	9	PS50005
Domain	CHCR	VPS18 VPS39 TGFBRAP1	2.80e-05	7	176	3	PS50236
Domain	Clathrin_H-chain/VPS_repeat	VPS18 VPS39 TGFBRAP1	4.45e-05	8	176	3	IPR000547
Domain	Arylamine_N-AcTrfase	NAT1 NAT2	8.83e-05	2	176	2	IPR001447
Domain	Acetyltransf_2	NAT1 NAT2	8.83e-05	2	176	2	PF00797
Domain	VPS39/TGF_beta_rcpt-assoc_1	VPS39 TGFBRAP1	8.83e-05	2	176	2	IPR019452
Domain	VPS39/TGF_beta_rcpt-assoc_2	VPS39 TGFBRAP1	8.83e-05	2	176	2	IPR019453
Domain	Vps39_2	VPS39 TGFBRAP1	8.83e-05	2	176	2	PF10367
Domain	Vps39_1	VPS39 TGFBRAP1	8.83e-05	2	176	2	PF10366
Domain	Spectrin_repeat	SYNE1 SPTB SPTBN5 PLEC	1.51e-04	29	176	4	IPR002017
Domain	ARM-like	PDS5B TOGARAM1 FHOD3 HUWE1 ELMO1 RANBP17 JUP HEATR6 MROH2B CTNNBL1	2.50e-04	270	176	10	IPR011989
Domain	ANF_RECEPTORS	NPR1 NPR2	2.63e-04	3	176	2	PS00458
Domain	ANPR/GUC	NPR1 NPR2	2.63e-04	3	176	2	IPR001170
Domain	ATPase_dyneun-rel_AAA	DNAH10 DNAH2 MDN1	2.77e-04	14	176	3	IPR011704
Domain	CNH	TNIK VPS39 CIT	2.77e-04	14	176	3	SM00036
Domain	AAA_5	DNAH10 DNAH2 MDN1	2.77e-04	14	176	3	PF07728
Domain	REJ	PKD1L2 PKD1	5.23e-04	4	176	2	PS51111
Domain	REJ_dom	PKD1L2 PKD1	5.23e-04	4	176	2	IPR014010
Domain	TPR-contain_dom	SH3TC2 TTC28 TTC3 VPS13A TTC21B PRMT9 ANAPC5	5.56e-04	150	176	7	IPR013026
Domain	LH2	PKD1L2 PKD1 ALOX12	6.05e-04	18	176	3	SM00308
Domain	-	PKD1L2 PKD1 ALOX12	9.66e-04	21	176	3	2.60.60.20
Domain	PLAT	PKD1L2 PKD1 ALOX12	9.66e-04	21	176	3	PF01477
Domain	PLAT/LH2_dom	PKD1L2 PKD1 ALOX12	9.66e-04	21	176	3	IPR001024
Domain	PLAT	PKD1L2 PKD1 ALOX12	9.66e-04	21	176	3	PS50095
Domain	-	PDS5B TOGARAM1 ELMO1 RANBP17 JUP HEATR6 MROH2B CTNNBL1	1.24e-03	222	176	8	1.25.10.10
Domain	Spectrin	SYNE1 SPTB SPTBN5	1.27e-03	23	176	3	PF00435
Domain	Dynamin_central	DNM3 DNM2	1.29e-03	6	176	2	IPR000375
Domain	Adcy_conserved_dom	ADCY5 ADCY6	1.29e-03	6	176	2	IPR009398
Domain	GED	DNM3 DNM2	1.29e-03	6	176	2	SM00302
Domain	PH_BEACH	NBEAL1 LYST	1.29e-03	6	176	2	PF14844
Domain	Dynamin_M	DNM3 DNM2	1.29e-03	6	176	2	PF01031
Domain	GED_dom	DNM3 DNM2	1.29e-03	6	176	2	IPR020850
Domain	DUF1053	ADCY5 ADCY6	1.29e-03	6	176	2	PF06327
Domain	PKD/REJ-like	PKD1L2 PKD1	1.29e-03	6	176	2	IPR002859
Domain	GED	DNM3 DNM2	1.29e-03	6	176	2	PS51388
Domain	REJ	PKD1L2 PKD1	1.29e-03	6	176	2	PF02010
Domain	Dynamin_GTPase_CS	DNM3 DNM2	1.29e-03	6	176	2	IPR019762
Domain	GED	DNM3 DNM2	1.29e-03	6	176	2	PF02212
Domain	GED	DNM3 DNM2	1.29e-03	6	176	2	IPR003130
Domain	PH	CIT ELMO1 SPTBN5 DNM3 PLEKHM3 PLD1 ACAP2 ACAP3 DNM2	1.32e-03	278	176	9	SM00233
Domain	PH_DOMAIN	CIT ELMO1 SPTBN5 DNM3 PLEKHM3 PLD1 ACAP2 ACAP3 DNM2	1.35e-03	279	176	9	PS50003
Domain	PH_domain	CIT ELMO1 SPTBN5 DNM3 PLEKHM3 PLD1 ACAP2 ACAP3 DNM2	1.38e-03	280	176	9	IPR001849
Domain	PH	CIT SPTBN5 DNM3 PLEKHM3 PLD1 ACAP2 ACAP3 DNM2	1.51e-03	229	176	8	PF00169
Domain	TPR_repeat	SH3TC2 TTC28 TTC3 TTC21B PRMT9 ANAPC5	1.64e-03	133	176	6	IPR019734
Domain	Clathrin	VPS18 TGFBRAP1	1.80e-03	7	176	2	PF00637
Domain	G_DYNAMIN_1	DNM3 DNM2	1.80e-03	7	176	2	PS00410
Domain	DYNc	DNM3 DNM2	1.80e-03	7	176	2	SM00053
Domain	Kinase-like_dom	TNIK DDR1 NPR1 NPR2 FLT4 CIT NEK9 PRKACG DNM3 ATM MAPK11 STK38L DNM2	1.92e-03	542	176	13	IPR011009
Domain	CYCLINS	CCNQ CCNK CCNH	2.27e-03	28	176	3	PS00292
Domain	DHC_N1	DNAH10 DNAH2	2.38e-03	8	176	2	PF08385
Domain	AC_N	ADCY5 ADCY6	2.38e-03	8	176	2	IPR032628
Domain	Adcy	ADCY5 ADCY6	2.38e-03	8	176	2	IPR030672
Domain	Cyclin_L/T	CCNQ CCNH	2.38e-03	8	176	2	IPR015429
Domain	PH-BEACH_dom	NBEAL1 LYST	2.38e-03	8	176	2	IPR023362
Domain	-	NBEAL1 LYST	2.38e-03	8	176	2	2.30.29.40
Domain	PH_BEACH	NBEAL1 LYST	2.38e-03	8	176	2	PS51783
Domain	AC_N	ADCY5 ADCY6	2.38e-03	8	176	2	PF16214
Domain	Dynein_heavy_dom-1	DNAH10 DNAH2	2.38e-03	8	176	2	IPR013594
Domain	PH_dom-like	NBEAL1 CIT LYST ELMO1 SPTBN5 DNM3 PLEKHM3 PLD1 ACAP2 ACAP3 DNM2	2.42e-03	426	176	11	IPR011993
Domain	BEACH	NBEAL1 LYST	3.04e-03	9	176	2	PS50197
Domain	Beach	NBEAL1 LYST	3.04e-03	9	176	2	PF02138
Domain	-	NBEAL1 LYST	3.04e-03	9	176	2	1.10.1540.10
Domain	Beach	NBEAL1 LYST	3.04e-03	9	176	2	SM01026
Domain	BEACH_dom	NBEAL1 LYST	3.04e-03	9	176	2	IPR000409
Domain	ZF_DAG_PE_1	MYO9B CIT RASGRP1 PLEKHM3	3.12e-03	64	176	4	PS00479
Domain	ZF_DAG_PE_2	MYO9B CIT RASGRP1 PLEKHM3	3.12e-03	64	176	4	PS50081
Domain	C1	MYO9B CIT RASGRP1 PLEKHM3	3.30e-03	65	176	4	SM00109
Domain	PE/DAG-bd	MYO9B CIT RASGRP1 PLEKHM3	3.49e-03	66	176	4	IPR002219
Domain	-	SH3TC2 TTC28 ST7L TTC3 TTC21B PRMT9 ANAPC5	3.53e-03	207	176	7	1.25.40.10
Domain	Cyclin_N	CCNQ CCNK CCNH	3.65e-03	33	176	3	PF00134
Domain	Cyclin_N	CCNQ CCNK CCNH	3.65e-03	33	176	3	IPR006671
Domain	HEAT_REPEAT	PDS5B TOGARAM1 HEATR6 MROH2B	4.31e-03	70	176	4	PS50077
Domain	Transglutaminase-like	TGM7 NGLY1	4.59e-03	11	176	2	IPR002931
Domain	TGc	TGM7 NGLY1	4.59e-03	11	176	2	SM00460
Domain	Transglut_core	TGM7 NGLY1	4.59e-03	11	176	2	PF01841
Domain	PKD_channel	PKD1L2 PKD1	4.59e-03	11	176	2	PF08016
Pubmed	Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription.	ID1 ID2 ID4 ANAPC1 ANAPC5	9.56e-09	15	178	5	35440621
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TNIK PDS5B FRAS1 TTC28 ZFYVE16 AVL9 SYNE1 ADCY6 ARFGEF3 MAGI2 PXDN SGSM2 DNM3 SLC9A6	2.77e-08	407	178	14	12693553
Pubmed	Characterization of the Mammalian CORVET and HOPS Complexes and Their Modular Restructuring for Endosome Specificity.	VPS18 VPS39 VIPAS39 TGFBRAP1	1.36e-07	10	178	4	26463206
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	AKAP6 TNIK TTC28 VPS39 SYNE1 TOGARAM1 LRCH1 ADCY6 DNM3 STK38L	2.77e-07	225	178	10	12168954
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	VPS18 ZFYVE16 AVL9 NBEAL1 USP46 RB1CC1 RAB11FIP1 FAM135B JUP VIPAS39 TGFBRAP1	2.86e-07	285	178	11	34369648
Pubmed	Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis.	ID1 ID2 ID4	5.25e-07	4	178	3	8922523
Pubmed	TH2 dominance and defective development of a CD8+ dendritic cell subset in Id2-deficient mice.	ID1 ID2 ID4	5.25e-07	4	178	3	12532109
Pubmed	Id gene expression as a key mediator of tumor cell biology.	ID1 ID2 ID4	5.25e-07	4	178	3	10197587
Pubmed	Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis.	ID1 ID2 ID4	5.25e-07	4	178	3	8989524
Pubmed	Suppression of chondrogenesis by Id helix-loop-helix proteins in murine embryonic orofacial tissue.	ID1 ID2 ID4	5.25e-07	4	178	3	19349107
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYO9B TUT7 MED1 CIT IQGAP1 HEATR6 PXDN ANAPC1 PLEC	1.09e-06	202	178	9	33005030
Pubmed	Helix-loop-helix proteins in Schwann cells: a study of regulation and subcellular localization of Ids, REB, and E12/47 during embryonic and postnatal development.	ID1 ID2 ID4	1.31e-06	5	178	3	9418957
Pubmed	The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3.	ID1 ID2 ID4	1.31e-06	5	178	3	8139914
Pubmed	Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.	ID1 ID2 ID4	1.31e-06	5	178	3	25778840
Pubmed	Gene discovery in the hamster: a comparative genomics approach for gene annotation by sequencing of hamster testis cDNAs.	SLC9C1 MROH2B DEUP1	1.31e-06	5	178	3	12783626
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	VPS18 ZFYVE16 LYST ADAM22 SPG21 ARFGEF3 JUP VIPAS39 COG6 VPS13A PLEKHM3 EIF3C PLD1	2.25e-06	504	178	13	34432599
Pubmed	Inhibitors of differentiation and DNA binding (Ids) regulate Math1 and hair cell formation during the development of the organ of Corti.	ID1 ID2 ID4	2.61e-06	6	178	3	16407553
Pubmed	Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.	ID1 ID2 ID4	2.61e-06	6	178	3	16682435
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PDS5B PARG HUWE1 MED1 CCNK ADCY6 IQGAP1 INTS5 MDN1 ANAPC1 EIF3C ATM PLEC ANAPC5 WDR62 DNM2	2.66e-06	774	178	16	15302935
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AKAP6 TTC28 VPS39 SYNE1 SPTB CEP290 HUWE1 TTC3 CIT ADAM22 IQGAP1 MAGI2 HEATR6 SGSM2 PKD1 DNM3 EIF3C ATM PLEC MTUS2 DNM2	2.95e-06	1285	178	21	35914814
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FRAS1 PCNX3 MYO9B VPS39 INPPL1 HUWE1 TTC3 CIT LYST INTS5 TNRC18 MDN1 SGSM2 PKD1 NINL OGDHL PYGB PLEC HERC1	4.40e-06	1105	178	19	35748872
Pubmed	The expression and roles of inhibitor of DNA binding helix-loop-helix proteins in the developing and adult mouse retina.	ID1 ID2 ID4	4.54e-06	7	178	3	21145943
Pubmed	Two murine and human homologs of mab-21, a cell fate determination gene involved in Caenorhabditis elegans neural development.	NPR1 TRPC4 LXN	4.54e-06	7	178	3	10556287
Pubmed	A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development.	ID1 ID2 ID4	4.54e-06	7	178	3	17604724
Pubmed	Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation.	ID1 ID2 ID4	4.54e-06	7	178	3	11756408
Pubmed	A role for Id2 in regulating photic entrainment of the mammalian circadian system.	ID1 ID2 ID4	4.54e-06	7	178	3	19217292
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	DDR1 VPS18 INPPL1 RB1CC1 CCNQ LYST NEK9 CCNK CCNH ANAPC1 DNM3 EIF3C PLEC MAPK11 STK38L ANAPC5 DNM2	4.92e-06	910	178	17	36736316
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PDS5B SYNE1 DNAH2 APOB CCDC77 TTC3 LYST ADCY6 RYR2 IQGAP1 CCNH TNRC18 MDN1 PXDN DNAJC11 VPS13A MED11 OGDHL ATM NGLY1 PLEC POLQ	5.07e-06	1442	178	22	35575683
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	SLC25A46 MYO9B VPS39 BRINP1 TTC3 ADAM22 RYR2 LSM12 DNAJC11 RARS2 PLD1 DNA2	5.19e-06	462	178	12	31138677
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	DNAH10 SYNE1 SPTB SPTBN5 PKD1 NINL EIF3C PLEC	5.88e-06	187	178	8	26460568
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	HAUS7 VPS18 TTC28 ZFYVE16 PARG CEP290 HUWE1 MED1 CCDC77 NEK9 LSM12 MED11 WRAP73 ACAP2	6.63e-06	645	178	14	25281560
Pubmed	SPE-39 family proteins interact with the HOPS complex and function in lysosomal delivery.	VPS18 VPS39 VIPAS39	7.24e-06	8	178	3	19109425
Pubmed	Recruitment of VPS33A to HOPS by VPS16 Is Required for Lysosome Fusion with Endosomes and Autophagosomes.	VPS18 VPS39 VIPAS39	7.24e-06	8	178	3	25783203
Pubmed	Structural basis of Vps33A recruitment to the human HOPS complex by Vps16.	VPS18 VPS39 VIPAS39	7.24e-06	8	178	3	23901104
Pubmed	A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.	HUWE1 RFX4 ADAM22 SPTBN5 TNRC18 CATSPER1 ANAPC1 TTC21B DNM3 EIF3C	8.84e-06	331	178	10	19490893
Pubmed	Mammalian CORVET is required for fusion and conversion of distinct early endosome subpopulations.	VPS18 VPS39 TGFBRAP1	1.08e-05	9	178	3	25266290
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	PDS5B IQGAP1 JUP MDN1 ANAPC1 DMBT1 PLEC STK38L DNM2	1.22e-05	272	178	9	31010829
Pubmed	Genetic link between renal birth defects and congenital heart disease.	FRAS1 CEP290 TBC1D32 PKD1	1.23e-05	28	178	4	27002738
Pubmed	Functional proteomics mapping of a human signaling pathway.	NPR1 FLT4 ZFYVE16 HUWE1 MORC4 TTC3 RYR2 JUP PKD1 EIF3C PLEC HERC1 DNM2	1.24e-05	591	178	13	15231748
Pubmed	EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.	VPS18 VPS39 RB1CC1 VPS13A ATM HERC1 RNF139	1.30e-05	150	178	7	32423001
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	FRAS1 CEP290 TBC1D32 PKD1 WDR62 DNM2	1.32e-05	100	178	6	25807483
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	PDS5B LRCH1 CIT VPS13A NINL STK38L	1.48e-05	102	178	6	10231032
Pubmed	A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.	HUWE1 MED1 ATM	1.54e-05	10	178	3	17478428
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	TTC28 RAB11FIP1 CCDC77 LRCH1 VIPAS39 ANAPC1 DNAJC11 NINL STK38L ANAPC5 WDR62	2.09e-05	446	178	11	24255178
Pubmed	RP58 controls neuron and astrocyte differentiation by downregulating the expression of Id1-4 genes in the developing cortex.	ID1 ID2 ID4	2.11e-05	11	178	3	22234186
Pubmed	Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model.	ADCY6 PKD1	2.60e-05	2	178	2	24994926
Pubmed	Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China?	NAT1 NAT2	2.60e-05	2	178	2	15770721
Pubmed	Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study.	NAT1 NAT2	2.60e-05	2	178	2	19549810
Pubmed	Adenylyl cyclase 6 deficiency ameliorates polycystic kidney disease.	ADCY6 PKD1	2.60e-05	2	178	2	24158982
Pubmed	Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases.	NAT1 NAT2	2.60e-05	2	178	2	17656365
Pubmed	N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.	NAT1 NAT2	2.60e-05	2	178	2	12135032
Pubmed	Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver.	NAT1 NAT2	2.60e-05	2	178	2	28888949
Pubmed	Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.	NAT1 NAT2	2.60e-05	2	178	2	17522066
Pubmed	Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. Evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2.	NAT1 NAT2	2.60e-05	2	178	2	1559981
Pubmed	Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation.	ID1 ID2	2.60e-05	2	178	2	19330020
Pubmed	Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.	NAT1 NAT2	2.60e-05	2	178	2	29214875
Pubmed	Chromosomal assignment of human ID1 and ID2 genes.	ID1 ID2	2.60e-05	2	178	2	8586447
Pubmed	The pseudokinase domains of guanylyl cyclase-A and -B allosterically increase the affinity of their catalytic domains for substrate.	NPR1 NPR2	2.60e-05	2	178	2	30696704
Pubmed	Neuronal expression of regulatory helix-loop-helix factor Id2 gene in mouse.	ID1 ID2	2.60e-05	2	178	2	8224536
Pubmed	N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population.	NAT1 NAT2	2.60e-05	2	178	2	26409796
Pubmed	Effects of microRNA-217 on proliferation, apoptosis, and autophagy of hepatocytes in rat models of CCL4-induced liver injury by targeting NAT2.	NAT1 NAT2	2.60e-05	2	178	2	30417525
Pubmed	ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells.	ID1 ID2	2.60e-05	2	178	2	15744343
Pubmed	Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.	NAT1 NAT2	2.60e-05	2	178	2	11266080
Pubmed	N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine.	NAT1 NAT2	2.60e-05	2	178	2	19379125
Pubmed	Knockout of adenylyl cyclase isoform 5 or 6 differentially modifies the β1-adrenoceptor-mediated inotropic response.	ADCY5 ADCY6	2.60e-05	2	178	2	31009605
Pubmed	Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice.	NAT1 NAT2	2.60e-05	2	178	2	29237750
Pubmed	The TGF-β signaling modulators TRAP1/TGFBRAP1 and VPS39/Vam6/TLP are essential for early embryonic development.	VPS39 TGFBRAP1	2.60e-05	2	178	2	20961651
Pubmed	The mouse genomic instability mutation chaos1 is an allele of Polq that exhibits genetic interaction with Atm.	ATM POLQ	2.60e-05	2	178	2	15542845
Pubmed	Id1 induces apoptosis through inhibition of RORgammat expression.	ID1 RORC	2.60e-05	2	178	2	18489764
Pubmed	Genetic regulation of aromatic amine N-acetylation in inbred mice.	NAT1 NAT2	2.60e-05	2	178	2	6976963
Pubmed	Update on consensus arylamine N-acetyltransferase gene nomenclature.	NAT1 NAT2	2.60e-05	2	178	2	10862519
Pubmed	Chimeric natriuretic peptide ACNP stimulates both natriuretic peptide receptors, the NPRA and NPRB.	NPR1 NPR2	2.60e-05	2	178	2	23186809
Pubmed	Glucocorticoid receptor-mediated transcriptional regulation of N-acetyltransferase 1 gene through distal promoter.	NAT1 NAT2	2.60e-05	2	178	2	22644701
Pubmed	Molecular genetic basis of rapid and slow acetylation in mice.	NAT1 NAT2	2.60e-05	2	178	2	1875909
Pubmed	NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant.	NAT1 NAT2	2.60e-05	2	178	2	15142281
Pubmed	5-methyl-tetrahydrofolate and the S-adenosylmethionine cycle in C57BL/6J mouse tissues: gender differences and effects of arylamine N-acetyltransferase-1 deletion.	NAT1 NAT2	2.60e-05	2	178	2	24205029
Pubmed	Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism.	NAT1 NAT2	2.60e-05	2	178	2	17961509
Pubmed	Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.	NAT1 NAT2	2.60e-05	2	178	2	18199719
Pubmed	Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.	NAT1 NAT2	2.60e-05	2	178	2	12037388
Pubmed	N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.	NAT1 NAT2	2.60e-05	2	178	2	19898993
Pubmed	Effects of genetic polymorphisms of N-Acetyltransferase on trichloroethylene-induced hypersensitivity dermatitis among exposed workers.	NAT1 NAT2	2.60e-05	2	178	2	19834256
Pubmed	Carcinogen metabolism, cigarette smoking, and breast cancer risk: a Bayes model averaging approach.	NAT1 NAT2	2.60e-05	2	178	2	21080951
Pubmed	Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.	ID2 ID4	2.60e-05	2	178	2	22380883
Pubmed	Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk.	NAT1 NAT2	2.60e-05	2	178	2	14564055
Pubmed	Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer.	NAT1 NAT2	2.60e-05	2	178	2	18006927
Pubmed	Discoidin Domain Receptor 1 (DDR1) tyrosine kinase is upregulated in PKD kidneys but does not play a role in the pathogenesis of polycystic kidney disease.	DDR1 PKD1	2.60e-05	2	178	2	31260458
Pubmed	Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene.	NAT1 NAT2	2.60e-05	2	178	2	25798622
Pubmed	RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition.	NAT1 NAT2	2.60e-05	2	178	2	21347396
Pubmed	ATP potentiates competitive inhibition of guanylyl cyclase A and B by the staurosporine analog, Gö6976: reciprocal regulation of ATP and GTP binding.	NPR1 NPR2	2.60e-05	2	178	2	21828054
Pubmed	The calcium paradoxon of renin release: calcium suppresses renin exocytosis by inhibition of calcium-dependent adenylate cyclases AC5 and AC6.	ADCY5 ADCY6	2.60e-05	2	178	2	17068292
Pubmed	Nat1 promotes translation of specific proteins that induce differentiation of mouse embryonic stem cells.	NAT1 NAT2	2.60e-05	2	178	2	28003464
Pubmed	Porcine natriuretic peptide type B (pNPPB) maintains mouse oocyte meiotic arrest via natriuretic peptide receptor 2 (NPR2) in cumulus cells.	NPR1 NPR2	2.60e-05	2	178	2	24615855
Pubmed	Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.	NAT1 NAT2	2.60e-05	2	178	2	11751443
Pubmed	Arylamine N-acetyltransferase 2 expression in the developing heart.	NAT1 NAT2	2.60e-05	2	178	2	15872051
Pubmed	Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts.	ID1 ID2	2.60e-05	2	178	2	8294468
Pubmed	Vasonatrin peptide stimulates both of the natriuretic peptide receptors, NPRA and NPRB.	NPR1 NPR2	2.60e-05	2	178	2	24699414
Pubmed	Molecular cloning of ID4, a novel dominant negative helix-loop-helix human gene on chromosome 6p21.3-p22.	ID1 ID4	2.60e-05	2	178	2	7665172
Pubmed	N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.	NAT1 NAT2	2.60e-05	2	178	2	25689677
Pubmed	Adenylyl cyclase 5-generated cAMP controls cerebral vascular reactivity during diabetic hyperglycemia.	ADCY5 ADCY6	2.60e-05	2	178	2	31162142
Pubmed	Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte.	NPR1 NPR2	2.60e-05	2	178	2	22133375
GeneFamily	Arylamine N-acetyltransferases	NAT1 NAT2	1.33e-04	3	121	2	1133
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	SPTB DNM3 PLEKHM3 PLD1 ACAP2 ACAP3 DNM2	4.75e-04	206	121	7	682
GeneFamily	EF-hand domain containing\|Spectrins	SPTB SPTBN5	9.13e-04	7	121	2	1113
GeneFamily	Guanylate cyclase receptors	NPR1 NPR2	9.13e-04	7	121	2	343
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL1 LYST	1.55e-03	9	121	2	1230
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY5 ADCY6	1.93e-03	10	121	2	53
Coexpression	JOHNSTONE_PARVB_TARGETS_3_UP	TNIK FRAS1 VPS18 DNAH2 FHOD3 HUWE1 MORC4 IQGAP1 TGFBI JUP PYGB ATM PLD1 DMBT1 ANAPC5	3.00e-07	433	178	15	M2240
Coexpression	GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP	AVL9 PARG AK9 PPCS NEK9 JUP ATM PLD1 SLC9A6	2.13e-06	166	178	9	M9015
Coexpression	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	ID1 ID2 BRINP1 LXN	9.15e-06	20	178	4	M5409
Coexpression	LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP	ID1 CIT SPTBN5 NINL TGM7 EIF3C WDR62	9.27e-06	108	178	7	MM1334
Coexpression	GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN	PDS5B LYST NEK9 NINL ATM STK38L ANAPC5 PLS3 TBCE	9.71e-06	200	178	9	M8403
Coexpression	GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	TNIK NIBAN1 AVL9 RB1CC1 MAGI2 INTS5 USP12 MIEF1 MACIR	9.71e-06	200	178	9	M8986
Coexpression	GAUTSCHI_SRC_SIGNALING	ID1 ID2 ID4	1.68e-05	8	178	3	M14722
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	PDS5B AVL9 MYO9B TOGARAM1 RB1CC1 ACAP2	2.53e-05	85	178	6	M10575
Coexpression	GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN	NBEAL1 RB1CC1 MAGI2 IGFBP6 USP12 PDE5A CDH8 ALOX12	2.85e-05	176	178	8	M8790
Coexpression	YAGI_AML_WITH_T_8_21_TRANSLOCATION	ENOSF1 DDR1 TTC28 APOB BRINP1 NUDCD3 TTC3 ELMO1 JUP PXDN SCML1	5.11e-05	372	178	11	M19261
Coexpression	BROWNE_HCMV_INFECTION_4HR_DN	AVL9 PARG CIT LYST NR2E1 NINL RORC PLEC MAPK11	5.98e-05	252	178	9	M789
Coexpression	GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	GPER1 POT1 USP46 RANBP17 MAGI2 RASGRP1 VPS13A USP12	6.33e-05	197	178	8	M8980
Coexpression	GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP	TUT7 CCDC77 TTC3 TGFBI TBC1D32 PYGB NGLY1 CDH8	6.56e-05	198	178	8	M9386
Coexpression	GSE40273_XBP1_KO_VS_WT_TREG_DN	SYNE1 ID2 LYST VPS13A PLEKHM3 LOXL3 PLEC HERC1	6.80e-05	199	178	8	M9124
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	AKAP6 NIBAN1 NBEAL1 TRPC4 ID4 PDE5A STK38L PLS3	7.60e-07	183	178	8	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 NIBAN1 SPTB FHOD3 ADCY5 RYR2 ADRA1A MTUS2	7.92e-07	184	178	8	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 NIBAN1 SPTB FHOD3 ADCY5 RYR2 ADRA1A MTUS2	8.25e-07	185	178	8	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	AKAP6 TTC28 ID4 ADCY5 RYR2 MAGI2 PDE5A PLS3	8.95e-07	187	178	8	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAT1 BTBD17 ID2 ID4 LXN RFX4 NR2E1 PYGB	1.09e-06	192	178	8	d2161842a38146261847fc9061ba9322e0f087e0
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	AKAP6 TNIK NIBAN1 FHOD3 RYR2 ADRA1A STK38L MTUS2	1.13e-06	193	178	8	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	AKAP6 TNIK NIBAN1 FHOD3 ADCY5 RYR2 ADRA1A MTUS2	1.23e-06	195	178	8	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	AKAP6 NIBAN1 NBEAL1 SYNE1 ID4 ADCY5 RYR2 PDE5A	1.48e-06	200	178	8	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 NIBAN1 SPTB FHOD3 RYR2 SLC9C1 MTUS2	7.07e-06	176	178	7	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	FLT4 IQCH SYNE1 ID2 RFX4 RORC ATM	7.07e-06	176	178	7	003076f1a983409ddf31b9c19e61c1facdd72566
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 CEP290 ADAM22 HEATR6 PDE5A HERC1 CDH8	7.61e-06	178	178	7	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 NIBAN1 SPTB FHOD3 RYR2 ADRA1A MTUS2	8.49e-06	181	178	7	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	AKAP6 NIBAN1 NBEAL1 TRPC4 ADCY5 PDE5A PLS3	9.12e-06	183	178	7	818fd886e0188091310825f9145fa53328f2c979
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYNE1 ID4 FHOD3 ADAM22 RYR2 SLC9C1 PDE5A	1.09e-05	188	178	7	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	AKAP6 NIBAN1 NBEAL1 TRPC4 RYR2 STK38L PLS3	1.09e-05	188	178	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYNE1 ID4 ADCY5 ADAM22 RYR2 MAGI2 PDE5A	1.12e-05	189	178	7	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PDS5B DBF4B CCDC77 CIT POLQ DNA2 WDR62	1.16e-05	190	178	7	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYNE1 ID4 ADCY5 ADAM22 RYR2 MAGI2 PDE5A	1.20e-05	191	178	7	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZFYVE16 AVL9 NBEAL1 HUWE1 MED1 ARFGEF3 TGFBRAP1	1.29e-05	193	178	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	AKAP6 IQCH DNAH10 SYNE1 DNAH2 AK9 ANKFN1	1.29e-05	193	178	7	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TNIK FRAS1 SYNE1 TBC1D32 VPS13A ATM HERC1	1.29e-05	193	178	7	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 HUWE1 TTC3 IQGAP1 VPS13A PDE5A HERC1	1.38e-05	195	178	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AKAP6 IQCH DNAH10 SYNE1 CEP290 DNAH2 AK9	1.47e-05	197	178	7	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	distal-mesenchymal-Vascular_Smooth_Muscle-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SPTB ID4 APOB ADCY5 RYR2 IGFBP6 PDE5A	1.47e-05	197	178	7	da653dc7d216e202f390e5ab0245f243e3ed213b
ToppCell	distal-2-mesenchymal-Vascular_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SPTB ID4 APOB ADCY5 RYR2 IGFBP6 PDE5A	1.52e-05	198	178	7	ce05ede69c167b2294630709bb0c223483a6ef75
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP6 SYNE1 FHOD3 ADCY5 RYR2 PDE5A PLS3	1.52e-05	198	178	7	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	LPS-antiTNF-Unknown-Endothelial-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH10 CIT ADCY5 RYR2 POLQ WDR62	1.53e-05	132	178	6	02491930097b75aaeedab9e8200711b0dc610944
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	FRAS1 NPR1 FLT4 ID2 JUP PLEC MACIR	1.57e-05	199	178	7	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	TRPC4 CEP290 ID2 RYR2 ARFGEF3 MAGI2 DNM3	1.57e-05	199	178	7	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TNIK FLT4 USP45 SYNE1 ID2 RASGRP1 RORC	1.57e-05	199	178	7	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	TRPC4 CEP290 ID2 RYR2 ARFGEF3 MAGI2 DNM3	1.57e-05	199	178	7	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	SYNE1 ID4 FHOD3 ADCY5 RYR2 TGFBI PDE5A	1.62e-05	200	178	7	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	IQCH DNAH10 DNAH2 AK9 ANKFN1 DEUP1 TP73	1.62e-05	200	178	7	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DDR1 MAGI2 ADRA1A NR2E1 NINL ANKFN1 MTUS2	1.62e-05	200	178	7	26f07d271e984f375145e4c10528fba44a5811e1
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2-L1-2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DDR1 MAGI2 ADRA1A NR2E1 NINL ANKFN1 MTUS2	1.62e-05	200	178	7	c3637827ceba16b0d7956c280dd2ddbc8b1ba55e
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	IQCH DNAH10 DNAH2 AK9 ANKFN1 DEUP1 TP73	1.62e-05	200	178	7	4992dbf0514d674017315dbd20d91dfec0c608e9
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_only / Treatment groups by lineage, cell group, cell type	AKAP6 NIBAN1 SYNE1 ID4 ADCY5 ADCY6 RYR2	1.62e-05	200	178	7	7c62678cf408aaaf98d6df0fb27814d2007c4521
ToppCell	Cerebellum-Macroglia-ASTROCYTE\|Cerebellum / BrainAtlas - Mouse McCarroll V32	NAT1 BTBD17 ID4 LXN RFX4 ADRA1A	3.26e-05	151	178	6	71841d2001200d1595c85c2b007ee20791a72927
ToppCell	Cerebellum-Macroglia-ASTROCYTE-Gja1\|Cerebellum / BrainAtlas - Mouse McCarroll V32	NAT1 BTBD17 ID4 LXN RFX4 ADRA1A	3.26e-05	151	178	6	60aced0c1cc6b509b73308d03d58a3c44d712ef4
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	SYNE1 ID4 ADCY6 AMIGO1 PLS3 WDR62	4.84e-05	162	178	6	2259e9536147e9cdee772e3a30ba7d104573262c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK NIBAN1 RSPH6A NUDT17 RANBP17 PRMT9	5.00e-05	163	178	6	4dfd408aa700e307478ee35f6b902f68719d8d9e
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SYNE1 ID4 ADCY6 AMIGO1 PLS3 WDR62	5.54e-05	166	178	6	89e2b8453180983533faccb4275867861876d7ee
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	SPTB FHOD3 ADCY5 PXDN PDE5A MTUS2	5.73e-05	167	178	6	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB RFX4 TLR5 DNM3 TGM7	5.86e-05	103	178	5	3f4e4600c8a9af3534479ca19905c3d31c4c55bb
ToppCell	Control\|World / group, cell type (main and fine annotations)	SYNE1 RAB11FIP1 ARFGEF3 RANBP17 SLC9C1 DMBT1	5.92e-05	168	178	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 ZFYVE16 ADAM22 RASGRP1 SCML1 BNIPL	6.32e-05	170	178	6	928e42c51a7079c506f21c669c4e4c1a0df84d77
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDR1 SH3TC2 WIPI1 ID1 SPTBN5 ALOX12	6.32e-05	170	178	6	fed8e982d2ce234c59d4016432ed8941df36df27
ToppCell	RV-03._Atrial_Cardiomyocyte\|RV / Chamber and Cluster_Paper	AKAP6 TRPC4 FHOD3 RYR2 GABRR3	6.43e-05	105	178	5	49e16b11f16e83a7d17d162c14bce991201bcc2a
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	FLT4 IQCH SYNE1 ID2 RFX4 RORC	7.42e-05	175	178	6	cc2428150987911d0d382e8177918724aa69f85c
ToppCell	10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT\|blood / Manually curated celltypes from each tissue	FLT4 USP45 ID2 FHOD3 IGFBP6 RORC	7.42e-05	175	178	6	b4e4b66e89f79999768a6192c8404cb2465f920b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 ID1 ID4 MAGI2 DNM3 MTUS2	7.90e-05	177	178	6	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	AKAP6 SYNE1 ADAM22 MDN1 DNM3 HERC1	7.90e-05	177	178	6	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAM22 TGFBI MAGI2 SLC9C1 IGFBP6 PDE5A	8.40e-05	179	178	6	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ID1 ID4 OTOP3 ADCY5 JUP DMBT1	8.66e-05	180	178	6	7c7c4d64ff99d0710a7d19d8bc29fc9217394db1
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NIBAN1 FRAS1 ARFGEF3 MAGI2 BNIPL GYG2	8.66e-05	180	178	6	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	mild_COVID-19_(asymptomatic)-T/NK_proliferative\|World / disease group, cell group and cell class (v2)	DBF4B RFX4 CIT POLQ DNA2 WDR62	9.21e-05	182	178	6	9adf90bb2808f234d53b89ca0ae07380478204ad
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	AKAP6 TNIK FHOD3 RYR2 SLC9C1 MTUS2	9.21e-05	182	178	6	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 BRINP1 ADCY5 MAGI2 PXDN DNM3	9.21e-05	182	178	6	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 DNAH10 APOB PKD1L2 RYR2 ARFGEF3	9.78e-05	184	178	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 DNAH10 APOB PKD1L2 RYR2 ARFGEF3	9.78e-05	184	178	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 DNAH10 APOB PKD1L2 RYR2 ARFGEF3	9.78e-05	184	178	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DDR1 ID1 ID4 OTOP3 ADCY5 DMBT1	1.01e-04	185	178	6	c3d1a312569f3d619f7295812741cbf068ec6c1f
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SH3TC2 DNM3 ANKDD1B PDE5A ALOX12 MACIR	1.01e-04	185	178	6	709236097cbfc254796fcc69b5f5178b73dad9bd
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SH3TC2 DNM3 ANKDD1B PDE5A ALOX12 MACIR	1.01e-04	185	178	6	af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28
ToppCell	356C-Lymphocytic-ILC-ILC-3\|ILC / Donor, Lineage, Cell class and subclass (all cells)	TUT7 INTS5 DNAJC11 PKD1	1.04e-04	61	178	4	d0b33a48ee2faf68b270f9279c630437f3e8b20b
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK ID2 TTC3 RASGRP1 BNIPL MAPK11	1.04e-04	186	178	6	11929e36d8c9b4c4bc2f5e912f139f474f91ab00
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AKAP6 NIBAN1 SYNE1 ID4 ADCY5 RYR2	1.04e-04	186	178	6	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK ENOSF1 TTC28 FHOD3 FAM135B NINL	1.04e-04	186	178	6	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NPR1 GPER1 ID2 RAB11FIP1 ANKDD1B MTUS2	1.07e-04	187	178	6	3d4e81183cb7f6522ae654ddac494662402aa86d
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPR1 GPER1 ID1 LRCH1 ELMO1 MAPK11	1.07e-04	187	178	6	d9d10ed7c905778a29a0dc3ced3eef02a6b1de5c
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	AKAP6 TNIK FHOD3 ADCY5 ADRA1A MTUS2	1.07e-04	187	178	6	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRCH1 ADCY6 RYR2 MAGI2 RARS2 ANAPC5	1.10e-04	188	178	6	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRCH1 ADCY6 RYR2 MAGI2 RARS2 ANAPC5	1.10e-04	188	178	6	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 ID4 ADCY5 RYR2 PDE5A PLS3	1.10e-04	188	178	6	61f010c165826b434ca3d27553d4c9e13d2c0c51
ToppCell	wk_15-18-Hematologic-Myeloid-Basophil\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	WIPI1 PCNX3 MYO9B CATSPER1 ABHD1 PLD1	1.10e-04	188	178	6	3638d85452de15a060146628fbbad9d2a36feb13
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRCH1 ADCY6 RYR2 MAGI2 RARS2 ANAPC5	1.10e-04	188	178	6	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 ID4 ADCY5 RYR2 PDE5A PLS3	1.10e-04	188	178	6	7553ef7de3575af4cf34704b405b551c1af8eb83
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AKAP6 ID4 ADAM22 RYR2 MAGI2 PDE5A	1.10e-04	188	178	6	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	10x5'v1-week_17-19-Hematopoietic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SPTB ADCY6 RYR2 DNM3 PDE5A ALOX12	1.10e-04	188	178	6	c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AKAP6 NIBAN1 ADCY5 RYR2 ADRA1A PDE5A	1.13e-04	189	178	6	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	AKAP6 TNIK NIBAN1 FHOD3 RYR2 MTUS2	1.13e-04	189	178	6	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AKAP6 NIBAN1 ADCY5 RYR2 ADRA1A PDE5A	1.13e-04	189	178	6	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AKAP6 NIBAN1 ADCY5 RYR2 ADRA1A PDE5A	1.13e-04	189	178	6	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AKAP6 NIBAN1 ADCY5 RYR2 ADRA1A PDE5A	1.13e-04	189	178	6	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 NIBAN1 SPTB ADCY5 RYR2 MTUS2	1.17e-04	190	178	6	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|World / Lineage and Cell class	ADCY6 RYR2 DNM3 PDE5A PLS3 ALOX12	1.17e-04	190	178	6	1d19b2bd55789bf13e1386332f46c605973d6f8e
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NIBAN1 SPTB ID4 ADCY5 ADCY6 RYR2	1.17e-04	190	178	6	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NBEAL1 PARG APOB RB1CC1 IQGAP1 EIF3C	1.20e-04	191	178	6	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	AKAP6 NIBAN1 FHOD3 ADCY5 RYR2 MTUS2	1.20e-04	191	178	6	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 NIBAN1 ID4 ADCY6 ADRA1A STK38L	1.20e-04	191	178	6	ff7874cc005760a8f3b2e8072fbe418b6bfacaa8
ToppCell	10x5'v1-week_14-16-Hematopoietic-MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TNIK ADCY6 RYR2 DNM3 PDE5A ALOX12	1.20e-04	191	178	6	7edc22e7e70697fb22690699efb352577162709b
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NBEAL1 PARG APOB RB1CC1 IQGAP1 EIF3C	1.20e-04	191	178	6	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NBEAL1 PARG APOB RB1CC1 IQGAP1 EIF3C	1.20e-04	191	178	6	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNIK SPTB ID2 CATSPER1 CTNNBL1 MACIR	1.23e-04	192	178	6	60a02e0ccdc8c7af9bc875b248467304fe0d24a4
ToppCell	10x5'v1-week_14-16-Hematopoietic-MK-MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TNIK ADCY6 RYR2 DNM3 PDE5A ALOX12	1.23e-04	192	178	6	b877d14be9d04ab0010e340909e3a23de92613db
ToppCell	droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 FRAS1 SPTB RYR2 PYGB MTUS2	1.23e-04	192	178	6	0bf99e029a06151092db1e8a0dcb45f4e688e771
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ID4 ADCY5 ADAM22 RYR2 MAGI2 PDE5A	1.23e-04	192	178	6	992d08092edbc68c47b945deb8708379738c239a
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	AKAP6 TNIK NIBAN1 FHOD3 RYR2 MTUS2	1.23e-04	192	178	6	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNIK SPTB ID2 CATSPER1 CTNNBL1 MACIR	1.23e-04	192	178	6	b223fca73e16668f69a78cf4457e349d01792540
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNIK SPTB ID2 CATSPER1 CTNNBL1 MACIR	1.23e-04	192	178	6	b5615a780b0ba24a8e554fac9238d3f0bcba52bc
Computational	Genes in the cancer module 65.	NPR1 NPR2 PDE5A	8.42e-05	10	98	3	MODULE_65
Drug	caffeine	AKAP6 NAT1 NAT2 SYNE1 NT5C1B ADCY5 ADCY6 RYR2 TGFBI CATSPER1 PKD1 PRKACG CTNNBL1 PYGB PDE5A SMPD1 ATM PLD1 MAPK11	9.66e-08	562	178	19	CID000002519
Drug	milrinone	NPR1 NPR2 SYNE1 CIT ADCY5 ADCY6 PRKACG PDE5A SMPD1 PLD1	3.01e-07	150	178	10	CID000004197
Drug	U46619	NPR1 NPR2 ADCY5 ADCY6 RYR2 TGFBI ADRA1A CATSPER1 TGFBRAP1 PKD1 PDE5A PLS3 ALOX12	4.13e-07	285	178	13	CID000005618
Drug	Methantheline bromide [53-46-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A	NPR2 AVL9 VPS39 ALS2CL LYST ADAM22 IGFBP6 GYG2 DMBT1 MAPK11 POLQ	4.78e-07	198	178	11	6254_UP
Drug	papaverine	NPR1 NPR2 ADCY5 ADCY6 RYR2 CATSPER1 PKD1 PDE5A SMPD1 PLD1	1.31e-06	176	178	10	CID000004680
Drug	Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; MCF7; HT_HG-U133A	FLT4 GPER1 MYO9B NEK9 ADAM22 VPS13A SMPD1 ATM PLD1 MAPK11	3.62e-06	197	178	10	5437_DN
Drug	2',3'-dideoxyadenosine	ENOSF1 NPR1 ADCY5 ADCY6 TGFBI PRKACG PYGB	3.68e-06	82	178	7	CID000020039
Drug	PDEs	AKAP6 NPR1 NPR2 AKAP3 ADCY5 ADCY6 PRKACG PDE5A	3.69e-06	116	178	8	CID003036959
Drug	phthalazine	FLT4 SYNE1 LYST PDE5A	4.61e-06	15	178	4	CID000009207
Drug	eye gene	NPR1 NPR2 MYO9B ADCY5 ADCY6 ADRA1A PYGB PDE5A LOXL3 PLD1 MAPK11 PLS3 ALOX12	7.18e-06	369	178	13	CID000004782
Drug	D-myo-inositol-1,4,5-triphosphate	NPR1 INPPL1 SPTB TRPC4 ADCY5 ADCY6 RYR2 RASGRP1 CATSPER1 PKD1 PRKACG PYGB SMPD1 PLD1 MAPK11 PLS3	1.07e-05	568	178	16	CID000000806
Drug	AC1MW7VF	ID1 RYR2 SMPD1 NGLY1	1.28e-05	19	178	4	CID000414699
Drug	MDL-12330A	NPR1 NPR2 ADCY5 ADCY6 PRKACG PDE5A	1.29e-05	66	178	6	CID000004024
Drug	NSC759576	NPR1 APOB ADCY5 ADCY6 RYR2 IQGAP1 TRMT10A CATSPER1 PKD1	2.03e-05	191	178	9	CID000003075
Drug	MnGTP	NAT1 NPR1 NPR2 LXN	2.37e-05	22	178	4	CID000160802
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; HL60; HT_HG-U133A	AKAP6 NPR1 FLT4 TRPC4 ID4 APOB ADAM22 SPTBN5 ADRA1A	2.49e-05	196	178	9	2742_UP
Drug	Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	AKAP6 IMPG1 TTC28 ID4 ADAM22 SPTBN5 MAGI2 IGFBP6 SMPD1	2.70e-05	198	178	9	4816_UP
Drug	8-isoprostaglandin E1	NPR1 APOB ADCY5 ADCY6 TGFBI ADRA1A PRKACG PYGB PDE5A ALOX12	2.99e-05	251	178	10	CID000000214
Drug	rolipram	AKAP6 ENOSF1 NPR1 NPR2 AKAP3 CIT ADCY5 ADCY6 PRKACG PDE5A	3.19e-05	253	178	10	CID000005092
Drug	AC1NBU2S	NPR1 NPR2 RYR2 CATSPER1 PKD1 PYGB PDE5A	3.82e-05	117	178	7	CID004473765
Drug	1-(5-isoquinolinesulfonyl)-2-methylpiperazine	ADCY5 ADCY6 TGFBI ADRA1A PRKACG SMPD1 PLD1 PLEC MAPK11 PLS3 ALOX12	3.89e-05	314	178	11	CID000003542
Drug	NSC226080	NIBAN1 FLT4 WIPI1 ID2 RB1CC1 CCNQ CCNK RYR2 SPG21 CCNH PKD1 RORC SMPD1 EIF3C ATM PLD1 MAPK11 PLS3	4.40e-05	782	178	18	CID000005040
Drug	plakin	SYNE1 SPTB SPTBN5 JUP PLEC PLS3	4.49e-05	82	178	6	CID000018752
Drug	Puromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A	ID1 ID2 ID4 TOGARAM1 LYST NEK9 RASGRP1 NFKBIE	5.48e-05	168	178	8	5310_UP
Drug	Erythrityl Tetranitrate	NPR1 NPR2	6.08e-05	2	178	2	DB01613
Drug	6-fluorocholesterol	LYST ATM	6.08e-05	2	178	2	CID000135206
Drug	25-fluorocholesterol	LYST ATM	6.08e-05	2	178	2	CID006454807
Drug	4-iodoaniline	NAT1 NAT2	6.08e-05	2	178	2	ctd:C013067
Drug	N-hydroxy-2-aminofluorene	NAT1 NAT2	6.08e-05	2	178	2	ctd:C001368
Drug	4-bromoaniline	NAT1 NAT2	6.08e-05	2	178	2	ctd:C023621
Drug	bromoacetanilide	NAT1 NAT2	6.08e-05	2	178	2	ctd:C056005
Drug	metobromuron	ID1 SMPD1	6.08e-05	2	178	2	CID000018290
Drug	2-(bromoacetylamino)fluorene	NAT1 NAT2	6.08e-05	2	178	2	ctd:C075748
Drug	mianserin	CIT ADCY5 ADCY6 ADRA1A SMPD1 LOXL3	6.27e-05	87	178	6	CID000004184
Drug	AC1L1BDQ	TRPC4 ADCY5 ADCY6 ADRA1A PRKACG PLD1 MAPK11 PLS3	6.73e-05	173	178	8	CID000001394
Drug	5'-GMP Na2	NPR1 NPR2 SYNE1 XPNPEP2 NT5C1B CCNH VPS13A DNM3 PDE5A MAPK11 DNM2	6.96e-05	335	178	11	CID000000761
Drug	motapizone	NPR1 ADCY5 ADCY6 PDE5A	7.36e-05	29	178	4	CID000065819
Drug	OD-q	NPR1 NPR2 ADCY5 ADCY6 PRKACG PDE5A MAPK11 ALOX12	8.55e-05	179	178	8	CID000001456
Drug	AC1LCT6N	NAT1 NAT2 ALOX12	9.81e-05	12	178	3	CID000606283
Drug	etorphine	LYST ADCY5 ADCY6 DNM3 DNM2	9.82e-05	59	178	5	CID000026721
Drug	arabinosyladenine	AKAP6 NAT1 NPR1 NPR2 CIT NT5C1B ADCY5 ADCY6 RYR2 ADRA1A PKD1 PRKACG PYGB PDE5A PLD1 MAPK11 PLS3	1.06e-04	762	178	17	CID000000191
Drug	9-beta-D-arabinofuranosylguanine	NPR1 NPR2 VPS39 CIT NT5C1B ADCY5 ADCY6 IQGAP1 RASGRP1 TRMT10A PRKACG DNM3 PYGB PDE5A PLD1 POLQ PLS3 DNM2	1.14e-04	843	178	18	CID000000765
Drug	daunorubicin HCl; Down 200; 1uM; PC3; HT_HG-U133A	TNIK SH3TC2 GPER1 POT1 CEP290 ID1 PLEC TBCE	1.16e-04	187	178	8	7511_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	TNIK WIPI1 ZFYVE16 SYNE1 JUP SCML1 DNM3 PLD1	1.20e-04	188	178	8	2370_UP
Drug	zaprinast	NPR1 NPR2 ADCY5 ADCY6 RYR2 PRKACG PDE5A	1.24e-04	141	178	7	CID000005722
Drug	AC1L1GU8	NPR1 NPR2 PRKACG PDE5A MAPK11	1.25e-04	62	178	5	CID000003843
Drug	KT5720	NPR1 NPR2 ADCY5 ADCY6 PRKACG PDE5A PLD1 MAPK11	1.25e-04	189	178	8	CID000003844
Drug	AC1L1BJN	NPR1 ADCY5 ADCY6	1.27e-04	13	178	3	CID000001467
Drug	clozapine; Down 200; 10uM; HL60; HT_HG-U133A	MYO9B USP46 SEMA4G RYR2 RANBP17 PYGB PLD1 WDR62	1.39e-04	192	178	8	6188_DN
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A	TNIK GPER1 NUDCD3 SMPD1 POLQ DNA2 ARMH3 ANAPC5	1.44e-04	193	178	8	5074_DN
Drug	Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	PDS5B TTC28 CEP290 NEK9 ADAM22 IGFBP6 PLEC DNM2	1.44e-04	193	178	8	5430_DN
Drug	Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A	NPR1 GPER1 DBF4B ADCY6 ADAM22 DNM3 GYG2 ATM	1.49e-04	194	178	8	2825_UP
Drug	Loracarbef [121961-22-6]; Up 200; 10.8uM; PC3; HT_HG-U133A	NPR1 DBF4B TRPC4 ST7L ADAM22 RORC PLD1 WDR62	1.55e-04	195	178	8	5073_UP
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	MYO9B ID4 LRCH1 NEK9 ADAM22 SMPD1 DMBT1 MAPK11	1.55e-04	195	178	8	3747_UP
Drug	prostaglandin F2	NPR1 LXN ADCY5 ADCY6 ADRA1A PYGB PDE5A NGLY1 PLD1 ALOX12	1.55e-04	306	178	10	CID000000160
Drug	K-Cl	NPR1 NPR2 FLT4 MYO9B ADCY5 ADCY6 RYR2 TGFBI ADRA1A SMPD1 PLD1 MAPK11 POLQ PLS3	1.56e-04	567	178	14	CID000004873
Drug	zardaverine	NPR1 ADCY5 ADCY6 PDE5A	1.56e-04	35	178	4	CID000005723
Drug	Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	NPR2 FLT4 TTC28 MYO9B RAB11FIP1 LYST INTS5 MAPK11	1.60e-04	196	178	8	2874_DN
Drug	Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; PC3; HT_HG-U133A	XPNPEP2 HUWE1 NEK9 SPTBN5 TGFBI PRKACG CDH8 DNM2	1.60e-04	196	178	8	4484_UP
Drug	Estrone [53-16-7]; Up 200; 14.8uM; PC3; HT_HG-U133A	AKAP6 SPTB ADAM22 SPTBN5 MAGI2 PDE5A ATM MAPK11	1.60e-04	196	178	8	6647_UP
Drug	Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A	FRAS1 GPER1 MYO9B ADAM22 ADRA1A RORC SMPD1 PLD1	1.60e-04	196	178	8	4151_DN
Drug	Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A	TTC28 MYO9B SEMA4G NFKBIE TLR5 GYG2 ATM MAPK11	1.60e-04	196	178	8	5257_DN
Drug	Procainamide	NAT1 NAT2 WIPI1	1.61e-04	14	178	3	ctd:D011342
Drug	Pentylenetetrazole [54-95-5]; Down 200; 29uM; PC3; HT_HG-U133A	ENOSF1 AVL9 MYO9B HEATR6 SGSM2 VPS13A DMBT1 ARMH3	1.66e-04	197	178	8	2092_DN
Drug	chlorpromazine	WIPI1 XPNPEP2 ADCY5 ADCY6 ADRA1A LOXL3 PLD1 PLS3	1.66e-04	197	178	8	CID000002726
Drug	Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; PC3; HT_HG-U133A	WIPI1 TRPC4 BRINP1 ADCY6 ADAM22 ADRA1A MAPK11 CDH8	1.66e-04	197	178	8	5759_UP
Drug	Allantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A	ZFYVE16 INPPL1 SPTB CEP290 RB1CC1 PPCS LYST ATM	1.66e-04	197	178	8	1800_UP
Drug	Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	PDS5B NPR2 WIPI1 ZFYVE16 CEP290 USP46 SGSM2 NFKBIE	1.66e-04	197	178	8	7449_DN
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A	PDS5B SH3TC2 NPR2 SYNE1 RYR2 NFKBIE SMPD1 PLD1	1.66e-04	197	178	8	6663_DN
Drug	Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A	TTC28 SYNE1 ALS2CL LYST HEATR6 SGSM2 STK38L DNM2	1.72e-04	198	178	8	7384_DN
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A	NPR2 GPER1 MYO9B LYST ADAM22 TLR5 DNM3 ATM	1.72e-04	198	178	8	5259_DN
Drug	Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ID4 BRINP1 NUDCD3 ADAM22 ADRA1A OGDHL GYG2 ATM	1.72e-04	198	178	8	1538_UP
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A	DBF4B LRCH1 NEK9 SPTBN5 TGFBI PRKACG MAPK11 ARMH3	1.78e-04	199	178	8	5959_UP
Drug	1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A	AVL9 MYO9B VPS39 APOB RSPH6A PPCS TGFBI SMPD1	1.78e-04	199	178	8	61_UP
Drug	Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	NIBAN1 GPER1 MYO9B ELMO1 PRKACG GYG2 MAPK11 WDR62	1.78e-04	199	178	8	3609_UP
Drug	8-pCPT-cGMP	NPR1 NPR2 LXN PRKACG PDE5A	1.80e-04	67	178	5	CID000123969
Drug	noradrealine	NPR1 ADCY5 ADCY6 RYR2 TGFBI ADRA1A CATSPER1 PKD1 PRKACG PYGB LOXL3 PLD1 MAPK11 PLS3	1.80e-04	575	178	14	CID000000951
Drug	N-hydroxy-4-acetylaminobiphenyl	NAT1 NAT2	1.81e-04	3	178	2	ctd:C001365
Drug	3,5-dimethylaniline	NAT1 NAT2	1.81e-04	3	178	2	CID000007949
Drug	Aminosalicylic Acid	NAT1 NAT2	1.81e-04	3	178	2	ctd:D010131
Drug	I 324	NAT1 NAT2	1.81e-04	3	178	2	CID000031230
Drug	Hair Dyes	NAT1 NAT2	1.81e-04	3	178	2	ctd:D006202
Drug	Glu-asp-gly	NAT1 NAT2	1.81e-04	3	178	2	CID000194641
Drug	Nesiritide	NPR1 NPR2	1.81e-04	3	178	2	DB04899
Drug	anatabine	ID1 SMPD1	1.81e-04	3	178	2	CID000011388
Drug	3-ethylaniline	NAT1 NAT2	1.81e-04	3	178	2	CID000011475
Drug	Tiabendazole [148-79-8]; Up 200; 19.8uM; PC3; HT_HG-U133A	AKAP6 FLT4 MYO9B ID4 NEK9 SPTBN5 ADRA1A WDR62	1.84e-04	200	178	8	4579_UP
Drug	tadalafil	NPR1 ID1 IGFBP6 PDE5A	2.17e-04	38	178	4	CID000110635
Drug	octopamine	ADCY5 ADCY6 ADRA1A NR2E1 PYGB LOXL3	2.18e-04	109	178	6	CID000004581
Drug	fenoldopam	CIT ADCY5 ADCY6 ADRA1A PLD1	2.22e-04	70	178	5	CID000003340
Drug	Ro-1724	CIT ADCY5 ADCY6 PRKACG PDE5A SMPD1	2.29e-04	110	178	6	CID000005087
Drug	8-Br	NPR1 NPR2 ADCY5 ADCY6 PRKACG PLD1 ALOX12	2.32e-04	156	178	7	CID000168120
Disease	platelet component distribution width	PDS5B SH3TC2 VPS18 FLT4 MYO9B DBF4B SYNE1 ST7L LRCH1 ADCY5 ELMO1 DNM3 ANKDD1B PYGB PLEC HERC1 PLS3	3.35e-06	755	177	17	EFO_0007984
Disease	lethal congenital contracture syndrome (is_implicated_in)	NEK9 ADCY6 DNM2	7.30e-06	7	177	3	DOID:0060558 (is_implicated_in)
Disease	cystic kidney disease (implicated_via_orthology)	CEP290 TTC21B DNM2	2.47e-05	10	177	3	DOID:2975 (implicated_via_orthology)
Disease	occupational dermatitis (is_implicated_in)	NAT1 NAT2	3.58e-05	2	177	2	DOID:4404 (is_implicated_in)
Disease	collagen disease (implicated_via_orthology)	TLR5 DNM3 DNM2	4.49e-05	12	177	3	DOID:854 (implicated_via_orthology)
Disease	right ventricular systolic volume measurement	FHOD3 RSPH6A PDE5A PLEC	5.67e-05	35	177	4	EFO_0021815
Disease	Malignant neoplasm of breast	AKAP6 NAT2 GPER1 VPS39 SYNE1 TRPC4 RB1CC1 NUDT17 TTC3 ALS2CL CCNH TRMT10A ADRA1A ATM ANAPC5 PLS3 MACIR TP73	8.74e-05	1074	177	18	C0006142
Disease	PR interval	AKAP6 PCNX3 LRCH1 RFX4 ADCY5 ADAM22 ELMO1 RYR2 MAGI2 JUP PLEC	2.13e-04	495	177	11	EFO_0004462
Disease	Uterine leiomyoma	SYNE1 DNAH2 COG6 DNM3 PLEKHM3	2.25e-04	91	177	5	HP_0000131
Disease	cancer (implicated_via_orthology)	FLT4 PPCS JUP ATM DNA2 ACAP2 ACAP3 TP73	2.27e-04	268	177	8	DOID:162 (implicated_via_orthology)
Disease	Primary microcephaly	CIT TRMT10A WDR62	3.00e-04	22	177	3	C0431350
Disease	centronuclear myopathy 1 (implicated_via_orthology)	DNM3 DNM2	3.54e-04	5	177	2	DOID:0111223 (implicated_via_orthology)
Disease	microcytic anemia (implicated_via_orthology)	DNM3 DNM2	3.54e-04	5	177	2	DOID:11252 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology)	DNM3 DNM2	3.54e-04	5	177	2	DOID:0110197 (implicated_via_orthology)
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	AKAP6 TTC28 TRPC4 BRINP1 FAM135B ELMO1 RYR2 RANBP17 MAGI2 SGSM2 DNAJC11 NINL HERC1 CDH8	3.59e-04	801	177	14	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	allergic contact dermatitis (is_implicated_in)	NAT1 NAT2	5.28e-04	6	177	2	DOID:3042 (is_implicated_in)
Disease	susceptibility to mononucleosis measurement	DNAH2 RYR2 MDN1 USP12	7.98e-04	69	177	4	EFO_0008403
Disease	Industrial Dermatosis	NAT1 NAT2	9.78e-04	8	177	2	C0086457
Disease	Dermatitis, Occupational	NAT1 NAT2	9.78e-04	8	177	2	C0028796
Disease	lung cancer (is_implicated_in)	NAT2 TRPC4 POT1 TP73	1.04e-03	74	177	4	DOID:1324 (is_implicated_in)
Disease	5-acetylamino-6-formylamino-3-methyluracil measurement	NAT1 NAT2	1.25e-03	9	177	2	EFO_0800950
Disease	mean platelet volume	PDS5B NIBAN1 TTC28 PCNX3 MYO9B RSPH6A ST7L LRCH1 ELMO1 DNM3 PLEC STK38L ACAP2 PLS3 ALOX12	1.30e-03	1020	177	15	EFO_0004584
Disease	interleukin 4 measurement	RORC ALOX12 MTUS2	1.31e-03	36	177	3	EFO_0008184
Disease	uterine fibroid	SYNE1 POT1 DNAH2 COG6 DNM3 ATM	1.32e-03	199	177	6	EFO_0000731
Disease	Mammary Carcinoma, Human	NAT2 GPER1 VPS39 SYNE1 RB1CC1 NUDT17 CCNH ATM MACIR TP73	1.33e-03	525	177	10	C4704874
Disease	Mammary Neoplasms, Human	NAT2 GPER1 VPS39 SYNE1 RB1CC1 NUDT17 CCNH ATM MACIR TP73	1.33e-03	525	177	10	C1257931
Disease	Mammary Neoplasms	NAT2 GPER1 VPS39 SYNE1 RB1CC1 NUDT17 CCNH ATM MACIR TP73	1.37e-03	527	177	10	C1458155
Disease	Small Lymphocytic Lymphoma	POT1 ATM	1.56e-03	10	177	2	C0855095
Disease	B-CELL MALIGNANCY, LOW-GRADE	POT1 ATM	1.56e-03	10	177	2	C1868683
Disease	Breast Carcinoma	NAT2 GPER1 VPS39 SYNE1 RB1CC1 NUDT17 CCNH ATM MACIR TP73	1.60e-03	538	177	10	C0678222
Disease	senile cataract (is_implicated_in)	NAT2 ATM	1.90e-03	11	177	2	DOID:9669 (is_implicated_in)
Disease	5-acetylamino-6-amino-3-methyluracil measurement	NAT1 NAT2	1.90e-03	11	177	2	EFO_0800951
Disease	renal cell carcinoma	POT1 ATM PLD1	2.05e-03	42	177	3	EFO_0000681
Disease	N-acetylputrescine measurement	NAT1 NAT2	2.27e-03	12	177	2	EFO_0800127
Disease	Mammary Neoplasms, Experimental	DDR1 ID1 ID4 ADCY5 CCNH	2.49e-03	155	177	5	C0024668
Disease	folic acid measurement	FLT4 MAGI2 DEUP1	2.67e-03	46	177	3	EFO_0005111
Disease	developmental and epileptic encephalopathy (implicated_via_orthology)	DNM3 DNM2	2.67e-03	13	177	2	DOID:0112202 (implicated_via_orthology)
Disease	Celiac Disease	MYO9B APOB MAGI2	2.83e-03	47	177	3	C0007570
Disease	obsolete_red blood cell distribution width	NPR2 WIPI1 TTC28 AVL9 MYO9B SPTB TUT7 APOB AK9 ST7L LRCH1 CIT IQGAP1 VPS13A PLD1 HERC1 DNM2	3.16e-03	1347	177	17	EFO_0005192
Disease	mean arterial pressure	ENOSF1 SH3TC2 NIBAN1 NPR1 PCNX3 MYO9B ST7L MED11 STK38L	3.31e-03	499	177	9	EFO_0006340
Disease	Fibrosis	NPR1 ADCY5 ATM	3.38e-03	50	177	3	C0016059
Disease	Cirrhosis	NPR1 ADCY5 ATM	3.38e-03	50	177	3	C1623038
Disease	basophil count, eosinophil count	PLB1 ELMO1 SLC9C1 COG6 ANAPC1 ATM	3.43e-03	241	177	6	EFO_0004842, EFO_0005090
Disease	mortality	SLC25A46 TTC28 NT5C1B VPS13A USP12	3.98e-03	173	177	5	EFO_0004352
Disease	Chromosome Aberrations	NAT1 POT1	4.06e-03	16	177	2	C0008625
Disease	vision disorder	MAGI2 PXDN	4.06e-03	16	177	2	MONDO_0021084
Disease	Autosome Abnormalities	NAT1 POT1	4.06e-03	16	177	2	C0004403
Disease	left ventricular diastolic function measurement	IQCH FHOD3 RSPH6A	4.21e-03	54	177	3	EFO_0008204
Disease	urate measurement, bone density	AKAP6 NAT1 FRAS1 PLB1 TTC28 SYNE1 PARG RANBP17 HEATR6 DMBT1	4.34e-03	619	177	10	EFO_0003923, EFO_0004531
Disease	Chronic Lymphocytic Leukemia	POT1 NFKBIE ATM	4.43e-03	55	177	3	C0023434
Disease	ovarian cancer (is_implicated_in)	POT1 APOB JUP	4.66e-03	56	177	3	DOID:2394 (is_implicated_in)
Disease	immature platelet fraction	MYO9B ST7L DNM3 PLEC	5.00e-03	114	177	4	EFO_0009187
Disease	progression free survival, ovarian carcinoma	FHOD3 ELMO1	5.14e-03	18	177	2	EFO_0001075, EFO_0004920
Disease	Libman-Sacks Disease	PCNX3 RASGRP1 TLR5	5.14e-03	58	177	3	C0242380
Disease	PROSTATE CANCER, HEREDITARY, 1	TTC28 MYO9B ATM	5.65e-03	60	177	3	C4722327
Disease	Alcoholic Intoxication, Chronic	NAT1 RFX4 ADCY5 SPG21 ANAPC1 CDH8	5.73e-03	268	177	6	C0001973
Disease	immature platelet measurement	MYO9B ST7L DNM3 PLEC	5.82e-03	119	177	4	EFO_0803541

Protein segments in the cluster

Peptide	Gene	Start	Entry
ADAHLLLAQVYLSQE	TTC21B	526	Q7Z4L5
VRLINSVNHYGLLID	NT5C1B	391	Q96P26
DILATNGVIHYIDEL	TGFBI	356	Q15582
HVQQYVLLLLSLGDT	ALS2CL	161	Q60I27
IHLLLQVTIDGRNYI	NAT1	106	P18440
SDLQVLEVLLLYNNH	AMIGO1	131	Q86WK6
AHQLYVLQVLTFNLL	ELMO1	291	Q92556
ESTEIALLNNIPYHE	PRMT9	521	Q6P2P2
YELLLIQQLNFHLIV	CCNH	146	P51946
QELLFHYLQLVASVE	CATSPER1	736	Q8NEC5
PDLYHLLVELNAVQS	CTNNBL1	131	Q8WYA6
IRVNHALDLYNTEIL	BRINP1	736	O60477
GLQVLITYNLHESIA	TBC1D32	626	Q96NH3
LNSIALHILYIVCQE	ACER1	146	Q8TDN7
ILLVFALALYLHAQQ	ADCY6	901	O43306
HVVLDHETYILNLTQ	SMPD1	511	P17405
THYYIVNLAVADLLL	ADRA1A	61	P35348
YLQVDLQRLHLVALV	DDR1	86	Q08345
LYNHISELVQLQEVA	RASGRP1	386	O95267
NSEYLVENALHLHLI	BTBD17	451	A6NE02
ILDVVLNHDLLSSEY	ADAM22	101	Q9P0K1
VLEDICHQILDLYSQ	CCNK	246	O75909
SEHYQRDIQTLILQV	CCDC77	211	Q9BR77
HLALDYVLQINVLQA	ACAP3	166	Q96P50
EAILLALYEAVHLNR	ARMH3	296	Q5T2E6
EALLYQILPHSVAEQ	NPR2	831	P20594
FRHIALDYVLQINVL	ACAP2	166	Q15057
VFVLALYLHAQQVES	ADCY5	996	O95622
EALLYQILPHSVAEQ	NPR1	846	P16066
FQAQHIAVAVLYLAL	CCNQ	186	Q8N1B3
QEILYQTHLISLDAQ	DEUP1	156	Q05D60
NLIQFYLAELILAVH	CIT	196	O14578
VLAEVAQHYQDTLIR	IQGAP1	571	P46940
TEEQLEIALAPYQHL	MTUS2	1221	Q5JR59
CEEELLQLLTHILNY	NBEAL1	1436	Q6ZS30
QSLAELEVLCTHLYI	RANBP17	6	Q9H2T7
HEIITLEQYQLCALA	PDS5B	896	Q9NTI5
LITQLYQEFDHLLEE	RFX4	376	Q33E94
VGSILIQIHEDLYQL	IQCH	11	Q86VS3
HYQQAELALQEAIRI	ANAPC5	316	Q9UJX4
DLNLETLSQAHVYII	ANAPC1	1451	Q9H1A4
LVLIILDERHDNYVL	RB1CC1	1506	Q8TDY2
LAYSLLLILQHIAQN	OTOP3	451	Q7RTS5
ERLFNLVHQAYEVLS	DNAJC11	56	Q9NVH1
QHVIDYIRDLQLELN	ID1	96	P41134
ALSDEHVQFLVYQLL	MAPK11	121	Q15759
LLLHSALVQETAYIE	LOXL3	531	P58215
SLLAVVDHLLDIYIQ	MDN1	491	Q9NU22
TQEDVNLGLIRYVLH	FRAS1	2506	Q86XX4
NHADILLINLQYVSE	LSM12	51	Q3MHD2
VDHELQQIIRDNLYL	MAGI2	121	Q86UL8
ILEVLQSNIQHVLVY	NGLY1	171	Q96IV0
VILALLQHDNIIAYY	NEK9	101	Q8TD19
HIVLYLLVISQESQQ	NUDT17	181	P0C025
AELYDQALLGILQHV	NUDCD3	6	Q8IVD9
QQLHLEIDSYSLNIE	IMPG1	666	Q17R60
VLDIQNNLYQTALHL	NFKBIE	286	O00221
VDLLYVQTLNSILHI	HERC1	4621	Q15751
LELLVAENYLLVHLS	BNIPL	246	Q7Z465
LLLIDIQVSYINTNH	DNM3	476	Q9UQ16
LCELVQHLIIFDYIS	ENOSF1	361	Q7L5Y1
LASDYLNALVHLIEV	PCNX3	1376	Q9H6A9
VNHLYADLQDALVIL	PLS3	416	P13797
ADTEVLQYQLQHLTL	MACIR	181	Q96GV9
VEDHLAVQSLIRAYQ	OGDHL	111	Q9ULD0
LEEAEAQHLYQSILP	PARG	581	Q86W56
GIVLHNAQLYETSLL	PDE5A	311	O76074
IDAICLQLYEALTHV	PDE5A	821	O76074
EIHLLFDQLISENYS	HEATR6	51	Q6AI08
IVDEQHLDFLLAYTI	HEATR6	111	Q6AI08
SLEILNLYHNCIRVI	LRCH1	121	Q9Y2L9
YDDLQVVTADHIQLI	MIEF1	191	Q9NQG6
EIQYHLLNTHLVAEV	ALOX12	356	P18054
LLQQIHLYSLADLQQ	PLEKHM3	636	Q6ZWE6
VEILQHVIDYILDLQ	ID4	91	P47928
HVIDYILDLQLALET	ID4	96	P47928
LLLIDIEQSYINTNH	DNM2	476	P50570
LHAISILVYSNALQE	HUWE1	281	Q7Z6Z7
AITTLHNLLLYQEGA	JUP	246	P14923
RQCLYLQLEHVEQEL	PKD1L2	1751	Q7Z442
ALEIYQHQVVVANIL	PPCS	246	Q9HAB8
SIYHLQNLTIEDLGA	TP73	516	O15350
VIEVNLIDSADYIHL	GYG2	91	O15488
AHLDTLINEQASYVL	COG6	531	Q9Y2V7
HINLELLECVYLVSA	EIF3C	676	Q99613
ILYNLYDLLVNEISH	ATM	311	Q13315
EQFLHRNIQEYLSIL	APOB	4441	P04114
ILENNHVIDTYSRIL	GABRR3	436	A8MPY1
VVLAVQYLHSLDLIH	PRKACG	151	P22612
IINSQNEYLIHLLQE	CEP290	776	O15078
EAHLYAEVDRIIAQL	DBF4B	326	Q8NFT6
VYIHALLAATLQLDN	AVL9	511	Q8NBF6
VSLLSHQVLLQNLYD	ARFGEF3	1716	Q5TH69
HQVLLQNLYDILLEE	ARFGEF3	1721	Q5TH69
GFVLENDLHILYLVT	POLQ	641	O75417
LVEQLNIYEVALRHE	FHOD3	311	Q2V2M9
HQLILAFLQVYDDEL	HAUS7	266	Q99871
LFILIHRQALESDYV	LYST	3336	Q99698
VHLLLQVTIDGRNYI	NAT2	106	P11245
YLLEVHENAALNSVI	CDH8	396	P55286
TDRLLDEIIQHIQLY	FAM135B	1191	Q49AJ0
DEIIQHIQLYNLSIS	FAM135B	1196	Q49AJ0
LALLEELYNSQLIVA	DNA2	726	P51530
VDLNQDLYVQAEILH	DMBT1	2276	Q9UGM3
DLYVQAEILHSDAVL	DMBT1	2281	Q9UGM3
TLEYGIINANVLHFL	DNAH10	126	Q8IVF4
AYLIERVQNNLHIVL	DNAH2	2876	Q9P225
YGIEVQDFLLHLLEV	RYR2	2476	Q92736
HLDSVLQQLQTEVYR	IGFBP6	166	P24592
VQHVEAELSAQIRYL	MED11	56	Q9P086
LILNLIRHQVAYNTL	MED1	406	Q15648
ALQDEAQLTLNSYIH	NR2E1	316	Q9Y466
QHVIEYSLALVTVLN	PKD1	2606	P98161
IELDYTILLHNIASQ	LXN	176	Q9BS40
QIHSIYSQLIILDLL	RNF139	146	Q8WU17
INCDLSLYEHLVNLL	RSPH6A	211	Q9H0K4
VSILQHLLRFDEVLY	RARS2	496	Q5T160
HNLQIIQDELERYLI	AK9	1276	Q5TCS8
AYAQLTHDELIQLVL	RAB11FIP1	1221	Q6WKZ4
VLIHCQVIYDALQNL	SCML1	61	Q9UN30
LTLENFYSNLILQHE	STK38L	26	Q9Y2H1
LAIFHELQVDVELYA	SLC9A6	236	Q92581
DVNHISLIFSILYLI	SLC9C1	241	Q4G0N8
QLREQYILHQTLLEE	SYNE1	5561	Q8NF91
NLVELYLHSNNIVVV	LRRC28	66	Q86X40
HAELEGNLVTELIYV	PLD1	881	Q13393
QHVIDYILDLQIALD	ID2	66	Q02363
LILVADSLIEVFNLH	GPER1	106	Q99527
QVDGILYTVLEANHI	MORC4	921	Q8TE76
HRLQNLTIDILVYDN	POT1	211	Q9NUX5
AYTIELLDTVALNLH	SGSM2	781	O43147
ADIEYLQDQHLLLTV	INPPL1	811	O15357
AIFIQQSLHLDLYLA	SLC5A11	166	Q8WWX8
AIHYLSQALVLGQLL	SH3TC2	776	Q8TF17
ILQLYTCLDQIQHIE	WRAP73	41	Q9P2S5
EVIYNTQSLLSLLVH	INTS5	771	Q6P9B9
TEYVQHIQQALDILS	PLB1	1226	Q6P1J6
RSAEVNLYVQIHLLQ	SPG21	261	Q9NZD8
ALEDQLLEILGTIYH	MROH2B	1041	Q7Z745
KELYVENAHLVRALQ	NINL	1331	Q9Y2I6
LAEIADILRQEQYHS	SPTBN5	486	Q9NRC6
QDTYVLHLVNQALRD	ABHD1	136	Q96SE0
DLIVSALLLIQYHLA	AKAP3	526	O75969
YSVNVIVDIHAVQLL	AKAP6	136	Q13023
QSNHVRIVEYLIQDL	ANKDD1B	176	A6NHY2
LDILLITIQDILSYH	ANKFN1	586	Q8N957
LLNLEHNYFVSISEL	C12orf4	141	Q9NQ89
QQILHRNLVYLATIA	SS18L1	51	O75177
HIYCLEQLLQEAIID	TNRC18	2201	O15417
HLAVLYLEEVLLQRA	TGFBRAP1	611	Q8WUH2
LQQQLLHEQALLLEY	TNIK	461	Q9UKE5
IHLHTEALLNTINYL	VPS13A	996	Q96RL7
QQDSQELLHYLLDAV	USP45	291	Q70EL2
EIALYTALVLINAHR	RORC	416	P51449
ENLVISLLQHSLYVG	SEMA4G	481	Q9NTN9
HVENVYEEILHQILL	NIBAN1	536	Q9BZQ8
SNQLIDENQLYLIAH	TBCE	261	Q15813
AVIIQYTLHAAVLQI	SLC25A46	391	Q96AG3
LGETEQAIHNYLLSL	VPS18	656	Q9P253
LVHITGNELYDIQLL	FLT4	221	P35916
LEQLYLHFNQIETLD	PXDN	136	Q92626
LEIIYAINQRHLDHV	PYGB	401	P11216
HEFLNYLLNTIADIL	USP12	126	O75317
HILEYATEISNLLDN	TTC41P	926	Q6P2S7
LNEAVDYVIRHLIQE	TTC3	866	P53804
IHENLLESLLELQAY	ST7L	331	Q8TDW4
QDHYTLLERQIIIEA	VIPAS39	291	Q9H9C1
EAILSNQEYTLAHLE	SPTB	1181	P11277
HENLTYLQLLERCVE	PLEC	2996	Q15149
LQALLEHYSELLVQA	WDR62	1496	O43379
SLEHLEQLAQYLLAE	UBL4B	126	Q8N7F7
ALQYHQLDLQIAEET	TTC28	1016	Q96AY4
AHEFLNYLLNTIADI	USP46	121	P62068
LAVNHVFEIILEYLE	TRMT10A	246	Q8TBZ6
IDVSLLSPEHLQYLN	XPNPEP2	601	O43895
VQALSQHVDNYLLLQ	TOGARAM1	1596	Q9Y4F4
QRLLVCLEESIYIHN	WIPI1	111	Q5MNZ9
DVFEGLSHLQVLYLN	TLR5	496	O60602
TLVAGHTLQIQLDLY	TGM7	661	Q96PF1
LEVDISLYNTLALHN	TUT7	1116	Q5VYS8
IILAAHTNNYEIIKL	TRPC4	146	Q9UBN4
QHYLNDLDSALIPVI	ZFYVE16	1501	Q7Z3T8
SLLENNIYVHDLLTF	VPS39	91	Q96JC1
QLILQLYILLEHGQA	XKR9	146	Q5GH70
QEQLAAIYAVLEHLP	MYO9B	1801	Q13459